![Comprehensive review of the detection methods for synthetic cannabinoids and cathinones. - Abstract - Europe PMC Comprehensive review of the detection methods for synthetic cannabinoids and cathinones. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4525208/bin/11419_2015_270_Fig1a_HTML.jpg)
Comprehensive review of the detection methods for synthetic cannabinoids and cathinones. - Abstract - Europe PMC
![Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI - Chin - 2008 - British Journal of Pharmacology - Wiley Online Library Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI - Chin - 2008 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/139dc44a-914a-48eb-a9ca-8bfa36a30e77/bph_367_f1.gif)
Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI - Chin - 2008 - British Journal of Pharmacology - Wiley Online Library
![Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model | Journal of Pharmacology and Experimental Therapeutics Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/362/1/210/F7.medium.gif)
Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model | Journal of Pharmacology and Experimental Therapeutics
![Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model | Journal of Pharmacology and Experimental Therapeutics Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/362/1/210/F1.large.jpg)
Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model | Journal of Pharmacology and Experimental Therapeutics
1-(Tetrahydro-2H-pyran-4-ylmethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | C22H29NO2 | ChemSpider
Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences
![Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A -834735, cathinone derivative 4-methoxy-α-PVP, and phenethylamine derivative 4-methylbuphedrine from ... Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A -834735, cathinone derivative 4-methoxy-α-PVP, and phenethylamine derivative 4-methylbuphedrine from ...](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11419-013-0194-5/MediaObjects/11419_2013_194_Fig2_HTML.gif)
Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A -834735, cathinone derivative 4-methoxy-α-PVP, and phenethylamine derivative 4-methylbuphedrine from ...
![PDF] Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model | Semantic Scholar PDF] Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bf98af8eec353f84e056d52ff546f252b46786a4/7-Table3-1.png)